Antithrombotic Therapy for VTE Disease

2024/03/06 by Scott M. Stevens, Scott C. Woller, Lisa Baumann Kreuziger +12 · 1 voice · 2 citations
Medicine · #Acute Ischemic Stroke Management #Atrial Fibrillation Management and Outcomes #Venous Thromboembolism Diagnosis and Management

paper · pdf · doi:10.1016/j.chest.2024.03.003

openalex publication_date 2024/03/06 · crossref created 2024/03/06 · openalex created_date 2024/03/07 · crossref issued 2024/08/01 · crossref published 2024/08/01 · crossref published-print 2024/08/01 · crossref deposited 2024/08/07 · openalex updated_date 2026/07/22 · crossref indexed 2026/07/28

Citations

• American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults

Cited by

• Compression hosiery to avoid post-thrombotic syndrome: CHAPS randomized clinical trial
• Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapy

Discussions

• March is Deep Vein Thrombosis Awareness Month—stay up to date with a recent Special Feature, Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. www.doi.org/10 [bsky, 1 points, 1 comments]